Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial (vol 18, pg 672, 2017)

被引：0
|
作者：
Garcia-Donas, J.
Font, A.
Perez-Valderrama, B.
机构：
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E9 / E9
页数：1
相关论文
共 50 条
  • [1] Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial
    Garcia-Donas, Jesus
    Font, Albert
    Perez-Valderrama, Begona
    Antonio Virizuela, Jose
    Angel Climent, Miquel
    Hernando-Polo, Susana
    Angel Arranz, Jose
    del Mar Llorente, Maria
    Lainez, Nuria
    Carlos Villa-Guzman, Jose
    Mellado, Begona
    Gonzalez del Alba, Aranzazu
    Castellano, Daniel
    Gallardo, Enrique
    Anido, Urbano
    Garcia del Muro, Xavier
    Domenech, Montserrat
    Puente, Javier
    Morales-Barrera, Rafael
    Luis Perez-Gracia, Jose
    Bellmunt, Joaquim
    [J]. LANCET ONCOLOGY, 2017, 18 (05): : 672 - 681
  • [2] Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma
    Bellmunt Molins, Joaquim
    Garcia-Donas Jimenez, Jesus
    Valderrama, Begona P.
    Virizuela Echaburu, Juan Antonio
    Hernando-Polo, Susana
    Climent Duran, Miguel Angel
    Carlos Villa-Guzman, Jose
    Arranz Arija, Jose Angel
    Llorente Ostiategui, Mar
    Lainez Milagro, Nuria
    Gonzalez-del-Alba, Aranzazu
    Mellado Gonzalez, Begona
    Gallardo Diaz, Enrique
    Castellano Gauna, Daniel
    Domenech Santasusana, Montserrat
    Anido Herranz, Urbano
    del Muro Solans, Xavier Garcia
    Luis Perez-Gracia, Jose
    Puente Vazquez, Javier
    Morales-Barrera, Rafael
    Font Pous, Albert
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 452 - 460
  • [3] Vinflunine maintenance therapy versus best supportive care (BSC) after platinum combination in advanced bladder cancer: A phase II, randomized, open-label study (MAJA study)-SOGUG 2011-02
    Macia, Sonia
    Garcia-Donas, Jesus
    Font Pous, Albert
    Domenech, Montserrat
    Garcia del Muro, Xavier
    Mellado, Begona
    Puente, Javier
    Arranz Arija, Jose Angel
    Climent Duran, Miguel Angel
    Lainez Milagro, Nuria
    Luis Perez-Gracia, Jose
    del Alba, Aranzazu Gonzalez
    Villa Guzman, Jose Carlos
    Perez-Valderrama, Begona
    Virizuela Echaburu, Juan
    Bonfill, Teresa
    Leon Mateos, Luis
    Morales-Barrera, Rafael
    Castellano, Daniel E.
    Bellmunt, Joaquim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial
    Mir, Olivier
    Cropet, Claire
    Toulmonde, Maud
    Le Cesne, Axel
    Molimard, Mathieu
    Bompas, Emmanuelle
    Cassier, Philippe
    Ray-Coquard, Isabelle
    Rios, Maria
    Adenis, Antoine
    Italiano, Antoine
    Bouche, Olivier
    Chauzit, Emmanuelle
    Duffaud, Florence
    Bertucci, Francois
    Isambert, Nicolas
    Gautier, Julien
    Blay, Jean-Yves
    Perol, David
    [J]. LANCET ONCOLOGY, 2016, 17 (05): : 632 - 641
  • [5] A cost-effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first-line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan
    Su, Po-Jung
    Xiao, Ying
    Lin, Amy Y.
    Goh, Connie
    Wu, Ethan
    Liu, Kevin
    Chou, Patrick
    Kuo, Kaitlin
    Palencia, Roberto
    Chang, Jane
    Kearney, Mairead
    Kapetanakis, Venediktos
    Benedict, Agnes
    [J]. CANCER REPORTS, 2023,
  • [6] A multicentre, international, randomised, open-label phase 3 trial of avelumab plus best supportive care (BSC) vs BSC alone as maintenance therapy after first-line platinum-based chemotherapy in patients with advanced urothelial cancer (JAVELIN bladder 100)
    Powles, T.
    Grivas, P.
    Aragon-Ching, J. B.
    Faroun, Y.
    Kessler, E. R.
    Tomita, Y.
    Chakrabarti, D.
    Laliberte, R. J.
    Shnaidman, M.
    Petrylak, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [7] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
    Powles, Thomas
    Loriot, Yohann
    Duran, Miguel A. Climent
    Sridhar, Srikala
    Bellmunt, Joaquim
    Petrylak, Daniel P.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    di Pietro, Alessandra
    Grivas, Petros
    Sternberg, Cora N.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 132 - 133
  • [8] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: prespecified subgroup analyses from JAVELIN Bladder 100
    Lumba, Sumit
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Andres
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Gupta, Shilpa
    Huang, Bo
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Powles, Thomas
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 42 - 43
  • [9] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: Prespecified subgroup analyses from JAVELIN Bladder 100
    Lumba, Sumit
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Anders
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Gupta, Shilpa
    Huang, Bo
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Powles, Thomas
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 126 - 126
  • [10] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
    Gurney, Howard
    Loriot, Yohann
    Powles, Thomas
    Duran, Climent Miguel
    Sridhar, Srikala
    Bellmunt, Joaquim
    Petrylak, Daniel
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    Di Pietro, Alessandra
    Grivas, Petros
    Sternberg, Cora
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 46 - 46
12345